Regulatory Story
Go to market news section View chart   Print
Company EnQuest PLC
TIDM ENQ
Headline

Publication of a Supplement to the Prospectus

Released 18:33 06-Feb-2013
Number 3171X18

RNS Number : 3171X
EnQuest PLC
06 February 2013
 

 

The information contained herein may only be released, published or distributed in the United Kingdom, Jersey, Guernsey or the Isle of Man. The information contained herein is not for release, publication or distribution in or into the United States, Australia, Canada, The Republic of Ireland, Japan, South Africa or in any other jurisdiction where it is unlawful to distribute this document.

 

 

 

6 February 2013



EnQuest PLC

Publication of a Supplement to the Prospectus dated 24 January 2013 and
Addendum to the Final Terms dated 24 January 2013, each relating to EnQuest PLC's proposed issue of Sterling denominated 5.50 per cent. Notes due 2022

 

 

EnQuest PLC today publishes a Supplement (the "Supplement") to its Prospectus dated 24 January 2013.

 

In addition, and as described in the Supplement, EnQuest PLC announces an addendum to the Final Terms dated 24 January 2013 (the "Final Terms").

 

Item 13(c)(Fixed Coupon Amount(s)), on page 2 of the Final Terms, now reads "£2.75 per Calculation Amount," and not "£2.25 per Calculation Amount."

 

The Supplement is available for viewing at:

 

http://www.rns-pdf.londonstockexchange.com/rns/3171X_1-2013-2-6.pdf

 

 

The Final Terms is available for viewing at:

 

http://www.rns-pdf.londonstockexchange.com/rns/3171X_-2013-2-6.pdf

 

 

 

 

Important Information

 

This announcement is not a prospectus for the purposes of EU Directive 2003/71/EC, as amended (the "Directive"), and/or Part VI of the Financial Services and Markets Act 2000. Investors should not subscribe for any notes referred to in this announcement except on the basis of information contained in the prospectus and the final terms relating to the issue of the notes. Full information on EnQuest and any offer of notes will only be available in a prospectus and the final terms and (if relevant) a final terms confirmation announcement published in respect of such notes. Investors will be able to obtain copies of the prospectus and the final terms and the final terms confirmation announcement on the website of the Regulatory News Services operated by the London Stock Exchange.

 

The distribution of this announcement and other information in connection with any offer in certain jurisdictions may be restricted by law and persons into whose possession this announcement or any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase. Any purchase of notes pursuant to any offer should only be made on the basis of the information contained in the relevant prospectus and the final terms, available as described above.

 

The notes will not be registered under the US Securities Act of 1933, as amended (the Securities Act) and, subject to certain exceptions, may not be offered, sold or delivered within the United States. Any notes will be offered and sold outside of the United States in reliance on Regulation S of the Securities Act, and may be subject to certain U.S. tax law requirements.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PDIBIGDDSDGBGXL
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Publication of a Supplement to the Prospectus - RNS